NeurIPS 2019 fact-sheets: overviews of the research we presented, and its future impact
What are driver mutations and why they are important?
From Patient Outcomes to Drug Development, biomarkers hold promise for improved care. But are there any caveats?
The need for a diverse universally accepted standard set of variants for machine learning
"Nothing in biology makes sense except in the light of evolution"
A call for greater protections amongst the US’s fractured legal landscape
Lessons from Professor J. Reardon’s The Postgenomic Condition (2017)
The real reason to get excited about our partnership to improve access to immunotherapies
A deep dive into the causes and consequences of tumour heterogeneity
Machine Learning can help provide valuable insights into the role genes have to play in the onset and treatment of disease
All cancer patients deserve better, personalised, treatment
Study of a cancer patient’s tumour DNA, and the mutations within it, gives us a window into that specific tumour
